On the fly News and insights, exclusive to thefly.com

SPCE

Virgin Galactic

$20.05 /

-0.68 (-3.28%)

, HQY

HealthEquity

$56.97 /

+1.79 (+3.24%)

09:55
10/23/20
10/23
09:55
10/23/20
09:55

Fly Intel: Pre-market Movers

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Virgin Galactic (SPCE) initiated with a Neutral at Goldman Sachs. 2. HealthEquity (HQY) initiated with an Outperform at RBC Capital. 3. Shaw Communications (SJR) initiated with an Equal Weight at Morgan Stanley. 4. Shutterstock (SSTK) initiated with a Buy at Stifel. 5. Pfizer (PFE), Merck (MRK), Eli Lilly (LLY) and AbbVie (ABBV) all initiated with a Buy at Truist, while Bristol-Myers (BMY) initiated with a Hold at the firm. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

SPCE

Virgin Galactic

$20.05 /

-0.68 (-3.28%)

HQY

HealthEquity

$56.97 /

+1.79 (+3.24%)

SJR

Shaw Communications

$17.82 /

+0.06 (+0.34%)

SSTK

Shutterstock

$62.30 /

+1.95 (+3.23%)

PFE

Pfizer

$37.83 /

+0.4 (+1.07%)

MRK

Merck

$79.61 /

+0.4 (+0.50%)

LLY

Eli Lilly

$143.11 /

+1.37 (+0.97%)

BMY

Bristol-Myers

$60.87 /

+0.11 (+0.18%)

ABBV

AbbVie

$84.10 /

-0.2 (-0.24%)

  • 27

    Oct

  • 27

    Oct

  • 27

    Oct

  • 27

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 02

    Nov

  • 05

    Nov

  • 05

    Nov

  • 01

    Jan

  • 20

    Feb

  • 27

    Mar

  • 31

    Mar

  • 20

    May

  • 03

    Jun

  • 09

    Jul

  • 06

    Aug

  • 12

    Aug

SPCE Virgin Galactic
$20.05 /

-0.68 (-3.28%)

10/23/20 Goldman Sachs
Virgin Galactic initiated with a Neutral at Goldman Sachs
09/28/20
Fly Intel: Top five analyst initiations
09/28/20 Susquehanna
Susquehanna starts Virgin Galactic with Positive rating, $20 price target
09/28/20 BofA
BofA starts Virgin Galactic with Buy rating, $35 price target
HQY HealthEquity
$56.97 /

+1.79 (+3.24%)

10/23/20 RBC Capital
HealthEquity initiated with an Outperform at RBC Capital
09/10/20 Deutsche Bank
HealthEquity price target raised to $60 from $57 at Deutsche Bank
09/09/20 Barrington
HealthEquity price target raised to $70 from $65 at Barrington
09/09/20 SVB Leerink
HealthEquity price target raised to $64 from $51 at SVB Leerink
SJR Shaw Communications
$17.82 /

+0.06 (+0.34%)

10/23/20 Morgan Stanley
Shaw Communications initiated with an Equal Weight at Morgan Stanley
10/02/20
Fly Intel: Top five analyst initiations
10/02/20 Barclays
Shaw Communications initiated with an Equal Weight at Barclays
09/11/20 National Bank
Shaw Communications price target raised to C$28 from C$27 at National Bank
SSTK Shutterstock
$62.30 /

+1.95 (+3.23%)

10/23/20 Stifel
Shutterstock initiated with a Buy at Stifel
10/23/20 JMP Securities
Shutterstock initiated with an Outperform at JMP Securities
09/29/20 BofA
Shutterstock initiated with a Buy at BofA
09/29/20 BofA
Shutterstock initiated with a Buy at BofA
PFE Pfizer
$37.83 /

+0.4 (+1.07%)

10/23/20 Piper Sandler
Ultragenyx deal with Solid Biosciences looks 'solid,' says Piper Sandler
10/23/20 Truist
Pfizer initiated with a Buy at Truist
10/14/20 SVB Leerink
BioNTech price target raised to $69 from $62 at SVB Leerink
10/12/20
Fly Intel: Top five analyst downgrades
MRK Merck
$79.61 /

+0.4 (+0.50%)

10/23/20 Truist
Merck initiated with a Buy at Truist
10/16/20 JPMorgan
Merck price target raised to $105 from $98 at JPMorgan
10/08/20 Piper Sandler
Moderna regains rights to adult RSV vaccine mRNA-1172, Piper ups target to $136
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
LLY Eli Lilly
$143.11 /

+1.37 (+0.97%)

10/23/20 Truist
Eli Lilly initiated with a Buy at Truist
10/16/20 JPMorgan
Eli Lilly price target raised to $200 from $190 at JPMorgan
10/14/20 JPMorgan
Eli Lilly risk/reward favorable into tirzepatide readout, says JPMorgan
10/14/20 Citi
Karuna Therapeutics trial news a positive, says Citi
BMY Bristol-Myers
$60.87 /

+0.11 (+0.18%)

10/23/20 Truist
Bristol-Myers initiated with a Hold at Truist
10/19/20
Fly Intel: Top five analyst upgrades
10/19/20 Guggenheim
Bristol-Myers upgraded to Buy after positive Opdivo data at Guggenheim
10/19/20 Guggenheim
Bristol-Myers upgraded to Buy from Neutral at Guggenheim
ABBV AbbVie
$84.10 /

-0.2 (-0.24%)

10/23/20 Truist
AbbVie initiated with a Buy at Truist
10/20/20 Goldman Sachs
Galapagos downgraded to Sell from Neutral at Goldman Sachs
10/16/20 JPMorgan
AbbVie price target raised to $120 from $115 at JPMorgan
09/29/20 Berenberg
AbbVie initiated with a Hold at Berenberg

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.